MGIM
CSTL icon

M&G Investment Management’s Castle Biosciences CSTL Stock Holding History

M&G Investment Management’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-95,351
Closed -$6.39K – 550
2021
Q3 		$6.39K Buy
95,351
+3,673
+4% +$258K 0.02% 361
2021
Q2 		$6.69K Buy
+91,678
New +$6.06M 0.02% 345

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

M&G Investment Management's CSTL Position: Q4 2021 in Review

M&G Investment Management sold out of Castle Biosciences (CSTL) in Q4 2021, closing a stake of 95,351 shares — an estimated $6.39K sold.

M&G Investment Management first reported a position in CSTL in Q2 2021 and held it in 2 quarters. The position peaked at $6.69K in Q2 2021. 159 funds tracked by Wall St. Rank hold CSTL as of Q4 2021.

  • M&G Investment Management reported no remaining Castle Biosciences position as of Q4 2021 after selling out during the quarter.
  • M&G Investment Management sold 95,351 Castle Biosciences shares in Q4 2021, an estimated $6.39K.
  • M&G Investment Management first reported a position in Castle Biosciences in Q2 2021 and held it in 2 quarters.
  • M&G Investment Management's Castle Biosciences position peaked at $6.69K in Q2 2021.
  • 159 funds tracked by Wall St. Rank held Castle Biosciences as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.